Infliximab for colitis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Jul 2023: Trial registered, NCT05947669
  2. 22 Aug 2023: Trial started, NCT05947669

The trials

NCT05947669: Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis

State
Under way
Phase
Phase 3
People
195 planned
Started
22 Aug 2023
Primary completion
Sep 2026
Arms
Treatment with infliximab
Results
None posted
  1. 17 Jul 2023: Trial registered
  2. 22 Aug 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as infliximab infusion; AZA placebo caps.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.